C3H 마우스 섬유육종의 온열치료시 Hydralazine이 미치는 영향
The Effect of Hydaralazine on Hyperthermic Treatment of C3H Mouse Fibrosarcoma
대한암학회지 1995년 27권 4호 p.671 ~ 679
박우윤, 하성환, 정강환,
소속 상세정보
박우윤 ( )
서울대학교
하성환 ( )
서울대학교
정강환 ( )
서울대학교
KMID : 0360319950270040671
Abstract
Hypoxic cells comprise 10~20% of tumor cells and are more sensitive to hyperthermia. By decreasing tumor blood flow artificially and thus increasing the hypoxic fraction in the tumor, the cytotoxic effect of hyperthermia can be increased.
Hydralazine is
an antihypertensive drug and its main mechanism is relaxation of the vascular smooth muscle of arterioles rather than veins. Administration of hydralazine causes a decrease in vascular resistance and an increase in blood flow in normal tissue,
but
since
the vasculature of tumor is not responsive to such a drug, blood flow in tumors is decreased because of steal phenomenon. Thus the hypoxic fraction in the tumor is in creased, and the tumor becomes more sensitive to hyperthermia.
Therefore, to evaluate the hydralazine effect on hyperthermia, the tumor growth delay was investigated and the change in the hypoxic fraction of the tumor was estimated using C3H mouse fibrosarcoma(FSaⅡ) with hypoxic fractions of usual range. In
6mm
FSaⅡtumors growing in the dorsum of the foot, administration of 5 or 10mg/kg of hydralazine was followed by 43℃hyperthermia for 60 minutes.
Tumor growth times (TGT) to reach a tumor volume of 500 mm* were 7.11±0.84 days and 7.44±1.13 days for controls and 10mg/kg of hydralazine only. TGT's for hyperthermia alone and administration of 5 or 10mg/kg of hydralazine followed by
hyperthermia
were 10.34±2.17 days. 13.38±1.82 days and 14.47±0.67 days, respectively. Elongation of tumor growth delay by administration of 5 or 10mg/kg of hydralazine in addition to hyperthermia were statistically significant (0.025respectively). Tumor control radiation doses (TCD50) were 69.6 (66.8-72.5) Gy for radiation alone, 80.9(76.2-85.7) Gy for radiation after administration of hydralazine (10mg/kg) and 81.7 (77.7-86.9) Gy for radiation under clamp hypoxia. The
hypoxic
fraction estimated from the TCD50's was 10.6% for controls and this was markedly increased to 86.2% by administration of hydralazine.
From the above results it was confirmed that the cytotoxic effect of hyperthermia was enhanced significantly by administration of hydralazine as a results of fnarked increased in the hypoxic fraction in the tumor.
키워드
원문 및 링크아웃 정보
등재저널 정보